Clinical Trials in Detroit

Showing 12921-12940 of 19,719 trials

Driveline Silicone Skin Interface Registry

NCT01577433

The purpose of this observational registry is to determine the freedom from driveline (DL) infection events in subjects implanted with a HeartMate II LVAD in whom only the silicone portion of the DL is externalized resulting in a silicone skin interface (SSI)

Driveline Heart-assisted Device Related Infection

Abbott Medical Devices400 participantsStarted May 2012

New Haven, Connecticut, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +12 more locations

UNKNOWNPhase 1< 1 mile

A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors

NCT02414516

This Phase 1a, single center, open-label, repeat dose study will evaluate the safety, efficacy, and Pharmacokinetics of ascending doses of OBP-801 in patients with advanced solid tumors.

Solid Tumor

Oncolys BioPharma Inc17 participantsStarted Mar 2015

Detroit, Michigan, United States

COMPLETEDNA< 1 mile

CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients

NCT01983293

The purpose of this study is to analyze the effect of left ventricular lead pacing location in the non-left bundle branch block (non-LBBB) heart failure patient population. The left ventricular lead pacing location will be guided by either the pacing site with the largest amount of dyssynchrony as measured by the LV electrical delay (QLV) or the physician's standard of care implant approach.

Non-left Bundle Branch BlockIschemic or Non-ischemic Cardiomyopathy

Abbott Medical Devices248 participantsStarted Nov 2013

Glendale, California, United States • Los Angeles, California, United States • Mission Viejo, California, United States +29 more locations

Driveline Silicone Skin Interface Registry

A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors

CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients

Find Trials by Condition in Detroit

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

Study of Itacitinib in Combination With Corticosteroids for the Treatment of Acute GVHD

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

A Comparison of High-intensity Interval Training Protocols on Health and Fitness

Lung Tissue Research Consortium

A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis

A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE)

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)

Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma

Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

Dating Matters: Strategies to Promote Healthy Teen Relationships

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)

An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis